NANO FANAVARAN DAROUEI AIVAND

NANO FANAVARAN DAROUEI AIVAND Company Profile

Company Type: Manufacturer (Factory)

NANO FANAVARAN DAROUEI AIVAND is an Iranian pharmaceutical company specializing in the research, development, and production of advanced nanotechnology-based drugs. The company is dedicated to improving human health by leveraging innovative nano-technology in pharmaceutical formulations. Their product portfolio typically includes various medications utilizing nano-delivery systems to enhance efficacy, reduce side effects, and improve patient compliance. They operate as a manufacturing entity with their own production facilities and R&D capabilities.

Based on available information, NANO FANAVARAN DAROUEI AIVAND (also known as AIVAND NANODARU) produces or markets the following products:

* **Doxorubicin-AIVAND:** Nano-liposomal doxorubicin hydrochloride injection

* **Paclitaxel-AIVAND:** Nano-albumin bound paclitaxel injection

* **Cisplatin-AIVAND:** Cisplatin injection

* **Oxaliplatin-AIVAND:** Oxaliplatin injection

* **Irinotecan-AIVAND:** Irinotecan injection

* **Gemcitabine-AIVAND:** Gemcitabine injection

* **Docetaxel-AIVAND:** Docetaxel injection

* **Carboplatin-AIVAND:** Carboplatin injection

These products are primarily focused on cancer treatment (chemotherapy).